PiPTapentadol – Wholesale PiPTapentadol
PiPTapentadol is a structural analogue of tapentadol featuring a piperidine-type substitution on the phenylpropylamine scaffold. PiPTapentadol is an opioid analgesic, a Tapentadol derivative with similar effects. This drug acts as an agonist of the μ opioid receptor and a norepinephrine reuptake inhibitor (NRI). This drug is a designer tool for detecting analgesic properties in laboratory conditions.
Price:
PiPTapentadol 5 g 100 $ Add to cart
PiPTapentadol 10 g 160 $ Add to cart
PiPTapentadol 50 g 380 $ Add to cart Free shipping!
PiPTapentadol 100 g 600 $ Add to cart Free shipping!
PiPTapentadol 500 g 2000 $ Add to cart Free shipping!
PiPTapentadol 1 kg 3500 $ Add to cart Free shipping!
PiPTapentadol – Structural and Pharmacological Overview
Chemical Classification
PiPTapentadol is a synthetic opioid analogue structurally derived from tapentadol, itself a centrally acting analgesic combining μ-opioid receptor agonism with norepinephrine reuptake inhibition (NRI).
In PiPTapentadol, the primary amine group of tapentadol is substituted with a piperidine or piperazine-type moiety, altering its receptor affinity and pharmacokinetic properties.
This modification places PiPTapentadol within the broader arylmethylamine / phenethylamine opioid family, alongside other designer analogues investigated in forensic toxicology and receptor mapping research.
Chemical Features
- Base structure: Derived from (±)-3-(3-hydroxyphenyl)-N,N-dimethylmethylbutanamine (tapentadol scaffold)
- Typical substitution: Replacement of the primary amine with piperidine or isopropylpiperidine (PiP) group
- Functional groups: Phenolic hydroxyl, tertiary amine, secondary alcohol
- Predicted molecular weight: ~275–310 g/mol (depending on salt form)
- Likely salt forms: Hydrochloride or fumarate
Pharmacology (Predicted from Structural Analogy)
- μ-Opioid Receptor Agonism (MOR):
The phenolic hydroxyl and basic amine group maintain MOR affinity similar to tapentadol, conferring analgesic and sedative properties in receptor assays. - Norepinephrine Reuptake Inhibition (NRI):
The extended amine side chain may preserve NRI activity, suggesting a dual mechanism combining opioid and noradrenergic modulation. - Reduced Serotonin Reuptake Affinity:
Compared to tramadol analogues, PiPTapentadol likely exhibits minimal serotonergic effect. - Expected effects (research observation):
- Central analgesia (MOR-mediated)
- Sedation, miosis, respiratory depression (dose-dependent)
- Elevated norepinephrine tone (mild stimulant-like property at low doses)
Toxicology and Safety Considerations
- No human pharmacokinetic data are available.
- As with all novel opioid analogues, PiPTapentadol presents high risk for respiratory depression, CNS depression, and dependence.
- Cross-tolerance with other opioids is likely but unpredictable.
- In forensic casework, analogues of tapentadol have been implicated in fatal overdoses when misused.
- Analytical detection may require LC-MS/MS with specific precursor ion transitions unique to the PiP-substituted moiety.
Forensic and Analytical Use
PiPTapentadol may appear in the context of:
- Designer opioid screening panels
- Toxicological reference standard development
- Structure–activity relationship (SAR) modeling for synthetic analgesics
Legal and Ethical Context
- Tapentadol is a controlled prescription opioid in most jurisdictions.
- Its analogues (including PiPTapentadol) are unapproved for medical use and may fall under analogue or NPS control laws.
- Any handling should comply with local controlled substance regulations and be limited to licensed analytical or academic laboratories.
Summary
PiPTapentadol is a tapentadol-derived experimental opioid analogue investigated for its unique receptor binding and pharmacological profile. It combines μ-opioid agonism with potential norepinephrine reuptake inhibition, but lacks formal toxicological, safety, or clinical data. Research use is strictly limited to controlled laboratory environments with full compliance to applicable regulations.

| Synonyms |
|
| IUPAC | 3-(2-methyl-1-(piperidin-1-yl)pentan-3-yl)phenol |
| Formula | C17H27NO |
| Molecular weight | 261.41 g/mol |
| CAS | |
| Appearance | A neat solid |
| Purity | ≥ 98 % |
-Choose your favorite products from Chems Axis , and you are guaranteed excellent quality at the best price.
-Envelopes are sent 24 hours after payment.
Delivery time 3-4 business days.
100% delivery speed throughout Europe.
-You must know the legal status of the product you order in your country.
-When ordering on our website from 250 US dollars, delivery at our expense. The manager automatically excludes shipping costs when ordering from $ 250.

